Emrullah Yilmaz
- Molecular Biology top 10%
- Genetics top 1%
- Cancer Research top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Olga A. GuryanovaŞevin TurcanFang FangDaniel RohleLogan A. WalshAdriana HeguyIngo K. MellinghoffTimothy A. Chan
- Topics
- Cancer Immunotherapy and Biomarkers (17 papers)Head and Neck Cancer Studies (17 papers)Lung Cancer Treatments and Mutations (10 papers)
- Journals
- NatureJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesJapanFrance
In The Last Decade
Emrullah Yilmaz
52 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 986
- Genetics 768
- Cancer Research 712
- Oncology 327
- Pulmonary and Respiratory Medicine 254
Countries citing papers authored by Emrullah Yilmaz
This map shows the geographic impact of Emrullah Yilmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emrullah Yilmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emrullah Yilmaz more than expected).
Fields of papers citing papers by Emrullah Yilmaz
This network shows the impact of papers produced by Emrullah Yilmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emrullah Yilmaz. The network helps show where Emrullah Yilmaz may publish in the future.
Co-authorship network of co-authors of Emrullah Yilmaz
This figure shows the co-authorship network connecting the top 25 collaborators of Emrullah Yilmaz. A scholar is included among the top collaborators of Emrullah Yilmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emrullah Yilmaz. Emrullah Yilmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 11 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 12 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 4 | |
| 14 | 49 | |
| 15 | 25 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 21 | |
| 20 | IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypebreakdown → | 1382 |
About Emrullah Yilmaz
Emrullah Yilmaz is a scholar working on Otorhinolaryngology, Biological Psychiatry and Oncology, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Head and Neck Cancer Studies (17 papers) and Lung Cancer Treatments and Mutations (10 papers). The work is most often cited by research in Genetics (768 citations), Cancer Research (712 citations) and Otorhinolaryngology (74 citations). Emrullah Yilmaz has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Olga A. Guryanova, Şevin Turcan, Fang Fang, Daniel Rohle, Logan A. Walsh, Adriana Heguy, Ingo K. Mellinghoff, Timothy A. Chan, Armida W. M. Fabius and Andrew Kaufman. Their work appears in journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.